Literature DB >> 24024475

Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib.

Masahiro Sekimizu1, Yuka Yamashita, Hideaki Ueki, Nobuhiro Akita, Hiroyoshi Hattori, Naoko Maeda, Keizo Horibe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24024475     DOI： 10.3109/10428194.2013.842984

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  Novel agents for the treatment of childhood acute leukemia.

Authors:  Colleen E Annesley; Patrick Brown
Journal:  Ther Adv Hematol       Date:  2015-04

2.  Nilotinib treatment induced large granular lymphocyte expansion and maintenance of longitudinal remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Masao Hagihara; Jian Hua; Morihiro Inoue; Tomoyuki Uchida; Shiro Ide; Shin Ohara; Tomoiku Takaku
Journal:  Int J Hematol       Date:  2020-01-01       Impact factor: 2.319
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.